Search Result

Search Result

Results for "

obesity epidemic

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Acyltransferase (1) PPAR (1)
By Research Areas:	Metabolic Disease (1)

Inhibitors & Agonists

Bibliotecas de Screening

Targets Recommended: Fat Mass and Obesity-associated Protein (FTO)

Cat. No.	Nombre del producto	Target	Áreas de investigación	Chemical Structure

HY-112489

FSG67 2 Publications Verification	Acyltransferase	Metabolic Disease
FSG67 is a glycerol 3-phosphate acyltransferase (GPAT) inhibitor with an IC₅₀ of 24 μM .

HY-13766

Timcodar VX-853	PPAR	Others
Timcodar is a macrolide agent, and studies have shown that during adipogenesis, timcodar can significantly inhibit fat accumulation, with an effect similar to that of rapamycin. However, unlike rapamycin, timcodar does not cause immunosuppression and glucose resistance. In addition, timcodar can effectively inhibit the adipogenic transcriptional regulators PPAR?? and C/EBP??, thereby inhibiting genes involved in fat accumulation. These studies lay the foundation for timcodar as a potential anti-obesity therapy, as obesity is becoming a global epidemic.

Cat. No.	Nombre del producto

HY-L199

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library	4,779 compounds
Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide and is the primary liver manifestation of metabolic syndrome. The growth of NAFLD has coincided with the obesity epidemic. NAFLD is composed of excess lipid accumulation in the liver, causing steatotoxicity, and shows a wide range of histopathological abnormalities. NAFLD may progress from simple steatosis to Non-alcoholic steatohepatitis (NASH) with or without fibrosis (NASH), and eventually to cirrhosis and hepatocellular carcinoma. To date, very few drugs have been approved for marketing specifically for the treatment of NAFLD, so increased efforts to develop NAFLD drugs are necessary. MCE designs a unique collection of 4,779 small molecules with definite or potential anti-NAFLD activity, which is an important tool for studying the pathological mechanism of NAFLD and developing drugs for NAFLD.

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

4,779 compounds

Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide and is the primary liver manifestation of metabolic syndrome. The growth of NAFLD has coincided with the obesity epidemic. NAFLD is composed of excess lipid accumulation in the liver, causing steatotoxicity, and shows a wide range of histopathological abnormalities. NAFLD may progress from simple steatosis to Non-alcoholic steatohepatitis (NASH) with or without fibrosis (NASH), and eventually to cirrhosis and hepatocellular carcinoma. To date, very few drugs have been approved for marketing specifically for the treatment of NAFLD, so increased efforts to develop NAFLD drugs are necessary.

MCE designs a unique collection of 4,779 small molecules with definite or potential anti-NAFLD activity, which is an important tool for studying the pathological mechanism of NAFLD and developing drugs for NAFLD.

Consulta en línea

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Saludo			Country or Region *
Nombre del solicitante *			Nombre de la Organizaciòn *
Department *
Direcciòn del E-mail *			Nombre del producto *
Cat. No.			Requested quantity *
Número de teléfono *
Observaciones

Consulta en línea

Inquiry Information

Nombre del producto:
Cat. No.:
Cantidad:
MCE Japan Authorized Agent:

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Atención al cliente: Technical Support; Servicio; Ordering Information; Devolución fácil; Tarifas y políticas de envío; Intellectual Property Promise

Fuentes de información: Normas de muestra gratis; Resources; Calculadora de molaridad; Calculadora de dilución; Terms & Conditions; Reconstitution Calculator; Specific Activity Calculator; DNA/RNA sequence conversion tools

Suscríbase a nuestro boletín

Name
E-mail *

	Sorry, but the email address you supplied was invalid.

Los productos son reactivos químicos para uso exclusivo en investigación y no están destinados al uso humano. No vendemos a pacientes.

Join with us